Updated:
CSPC NBP Pharmaceutical
CSPC NBP Pharmaceutical was established in 2003. Cai Dongchen serves as the ultimate controlling person via his chairmanship of CSPC Pharmaceutical Group...
CSPC NBP Pharmaceutical
CSPC NBP Pharmaceutical was established in 2003. Cai Dongchen serves as the ultimate controlling person via his chairmanship of CSPC Pharmaceutical Group Limited, the 100 percent indirect owner. The firm focuses on pharmaceutical production and licensing. Asset classes center on intellectual property and industrial real estate tied to its Shijiazhuang production base. It maintains licensing agreements with AstraZeneca and BeiGene for AI-driven small-molecule programs. Geographic activity remains concentrated in China with global IP reach. No public data exist on team size or additional offices. The firm lists membership in the China Pharmaceutical Equipment Association and the China Vaccine Industry Association. A related philanthropic vehicle is the Hebei CSPC Puen Charity Foundation. Ownership flows through CSPC Pharmaceutical Group Limited, with Key Honesty Limited holding shares linked to employee awards. This structure separates operating control from direct family ownership disclosure.
General information
Firm type
Corporate Investor
Year founded
2003
Location
Region
Asia
Country
China
City
Shijiazhuang
Corporate office
Shijiazhuang, Hebei, China
Principals
Cai Dongchen
Chairman of CSPC Pharmaceutical Group
Sector focus
Frequently asked questions
Who runs investment decisions at CSPC NBP Pharmaceutical?
Cai Dongchen holds ultimate control as chairman of the parent CSPC Pharmaceutical Group. Decisions align with group-level pharmaceutical strategy.
Does CSPC NBP Pharmaceutical participate in fund commitments or only direct deals?
Activity centers on direct licensing partnerships and internal production assets. No fund commitments appear in available records.
Where does the underlying wealth come from?
Wealth traces to pharmaceutical manufacturing operations of the CSPC group. No separate family wealth origin is disclosed.
How is CSPC NBP Pharmaceutical related to CSPC Pharmaceutical Group Limited?
CSPC Pharmaceutical Group Limited serves as the 100 percent indirect owner. The relationship structures all operational and investment activity.
Does CSPC NBP Pharmaceutical maintain philanthropic structures?
The Hebei CSPC Puen Charity Foundation operates as the associated philanthropic vehicle.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: